# Copalchi (Hintonia latiflora)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/copalchi-hintonia-latiflora
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-04-02
**Evidence Score:** 1 / 10
**Category:** South American
**Also Known As:** Hintonia latiflora, Coutarea latiflora, copalchi bark, quina amarilla, palo amargo

## Overview

Copalchi contains 4-phenylcoumarins and chlorogenic acid that inhibit α-glucosidase enzymes and modulate postprandial glucose absorption to produce hypoglycemic and antihyperglycemic effects. In streptozotocin-induced diabetic rat models, CH₂Cl₂-MeOH leaf and bark extracts significantly reduced [blood glucose](/ingredients/condition/weight-management) (p<0.05 vs. vehicle controls), though no controlled human clinical trials have yet quantified effect sizes in diabetic patients.

## Health Benefits

- **[Blood Glucose](/ingredients/condition/weight-management) Regulation**: 4-phenylcoumarins and chlorogenic acid inhibit intestinal α-glucosidases, slowing carbohydrate [digestion](/ingredients/condition/gut-health) and blunting postprandial glucose spikes in both normal and streptozotocin-induced diabetic rat models.
- **Antihyperglycemic Activity**: Leaf and bark extracts demonstrated statistically significant reductions in fasting and postprandial blood glucose (p<0.05) in preclinical rodent studies, with leaf extracts showing efficacy comparable to traditional bark preparations.
- **Gastroprotective Effects**: Bioactive coumarins and polyphenols activate endogenous sulfhydryl groups in gastric mucosa, preserving mucosal integrity and reducing lesion formation consistent with the plant's centuries-old use for gastrointestinal disorders.
- **[Antioxidant Activity](/ingredients/condition/antioxidant)**: Chlorogenic acid and ursolic acid contribute significant free-radical scavenging capacity, which may synergize with glucose-lowering effects to reduce oxidative stress associated with hyperglycemia.
- **Anti-inflammatory Potential**: Polyphenolic constituents including coutareagenin and ursolic acid modulate pro-[inflammatory pathway](/ingredients/condition/inflammation)s, potentially reducing low-grade systemic inflammation associated with type 2 diabetes and metabolic syndrome.
- **Digestive Support**: Traditional decoctions of bark and leaves have been used since the 16th century to manage gastrointestinal cramping, diarrhea, and dyspepsia, consistent with the gastroprotective mechanisms identified in modern phytochemical studies.

## Mechanism of Action

The primary hypoglycemic mechanism involves competitive inhibition of intestinal α-glucosidase enzymes by 4-phenylcoumarins—including 6′′-O-acetyl-5-O-β-D-galactopyranosyl-7,4′-dihydroxy-4-phenylcoumarin and desoxycordifolinic acid—thereby slowing hydrolysis of dietary oligosaccharides and reducing the rate of glucose entry into systemic circulation. Chlorogenic acid, the dominant compound in leaf infusions as confirmed by HPLC profiling, independently modulates glucose transport and may also inhibit glucose-6-phosphate translocase activity in hepatic microsomes, contributing to reduced hepatic glucose output. Gastroprotective effects arise through coumarin-mediated stimulation of endogenous sulfhydryl groups within the gastric mucosa, which stabilize mucosal defenses against ulcerogenic stimuli. Ursolic acid and polyphenolic fractions further suppress NF-κB-associated inflammatory signaling, providing complementary [anti-inflammatory](/ingredients/condition/inflammation) and [antioxidant activity](/ingredients/condition/antioxidant) that may protect pancreatic beta-cell function under chronic hyperglycemic conditions.

## Clinical Summary

No formal human clinical trials with defined sample sizes, randomization, or quantified effect sizes have been published for Hintonia latiflora as of the available literature. Preclinical evidence from streptozotocin-diabetic rat models consistently demonstrates significant antihyperglycemic activity (p<0.05 vs. vehicle), and isolated 4-phenylcoumarins retain direct hypoglycemic activity in bioassay fractionation, supporting biological plausibility. Safety-relevant clinical observations include case reports of acute hepatotoxicity with elevated ALT and AST in patients consuming continuous bark decoctions, which constitutes the primary human-derived clinical signal available. Confidence in clinical efficacy for diabetes management in humans remains low, and the ingredient should be considered investigational pending controlled human trial data.

## Nutritional Profile

Hintonia latiflora is not consumed as a food and does not contribute meaningful macronutrients or micronutrients in typical medicinal doses. The primary pharmacologically relevant phytochemicals are 4-phenylcoumarins—including 6′′-O-acetyl-5-O-β-D-galactopyranosyl-7,4′-dihydroxy-4-phenylcoumarin, desoxycordifolinic acid, coutareagenin, and acetylated analogues—present in bark and leaf tissues at concentrations that vary by geographic population and phenological stage, though absolute mg/g values have not been standardized across published studies. Chlorogenic acid is the dominant polyphenol in leaf infusions as confirmed by HPLC profiling across ten wild populations, with ursolic acid also identified as a secondary constituent. The bioavailability of phenylcoumarins from aqueous infusions versus hydroalcoholic extracts has not been directly compared in pharmacokinetic studies, and the impact of food matrix or gastrointestinal conditions on absorption efficiency remains uncharacterized.

## Dosage & Preparation

- **Traditional Bark Decoction**: Bark pieces simmered in water for 15–20 minutes; consumed as a tea 1–2 times daily—dose unstandardized, historically guided by empirical use in Mexican folk medicine.
- **Leaf Infusion (Aqueous)**: Dried leaves steeped in boiling water for 10–15 minutes; advocated as a sustainable alternative to bark harvesting with comparable HPLC-confirmed bioactive profiles.
- **Hydroalcoholic Extract (CH₂Cl₂-MeOH)**: Used in preclinical studies demonstrating antidiabetic activity; no equivalent commercial standardized extract product dose has been established for human use.
- **Standardization**: The Mexican Herbal Pharmacopoeia includes a quality monograph for H. latiflora bark specifying HPLC identification of 4-phenylcoumarins and chlorogenic acid as marker compounds; no standardized percentage content for commercial supplements has been universally adopted.
- **Effective Dose Range**: No clinically validated human dose range exists; animal studies used variable extract doses without direct human dose equivalents established through pharmacokinetic bridging studies.
- **Timing**: Traditional use suggests pre-meal or with-meal consumption consistent with the proposed α-glucosidase inhibition mechanism targeting postprandial glucose.

## Safety & Drug Interactions

Acute hepatotoxicity, manifesting as significantly elevated serum ALT and AST, has been reported in case series of patients consuming continuous decoctions of H. latiflora bark (syn. Coutarea latiflora), representing the most serious documented safety concern and necessitating [liver function](/ingredients/condition/detox) monitoring in long-term users. Leaf extracts assessed using the Lorke acute toxicity protocol in mice were classified as non-toxic, suggesting the hepatotoxic constituents may be more concentrated in bark or produced during prolonged bark processing. No formal drug interaction studies exist, but pharmacodynamic interactions with insulin, sulfonylureas, metformin, or other antidiabetic agents are theoretically plausible given the demonstrated α-glucosidase inhibitory and hypoglycemic activity, raising the risk of additive hypoglycemia. Safety in pregnancy and lactation has not been evaluated in any published study, and use should be avoided in these populations; individuals with pre-existing hepatic disease should avoid bark-derived preparations entirely pending further safety characterization.

## Scientific Research

The evidence base for Hintonia latiflora is currently limited to traditional use documentation and preclinical animal studies, with no published randomized controlled trials in human subjects identified in the literature. In vivo rodent studies using CH₂Cl₂-MeOH leaf extracts from both H. latiflora and the related species H. standleyana demonstrated statistically significant [blood glucose](/ingredients/condition/weight-management) reductions (p<0.05) in both normoglycemic and streptozotocin-induced diabetic rat models, establishing proof-of-concept for antidiabetic activity. Phytochemical characterization studies using HPLC across ten geographically diverse plant populations confirmed chlorogenic acid as the dominant marker compound, and isolated phenylcoumarins (compounds 1 and 2 from H. standleyana) showed direct hypoglycemic activity in bioassay-guided fractionation. Hepatotoxicity case reports in humans consuming bark preparations represent important clinical safety signals, but these are based on case series rather than systematic observation, leaving the full human safety and efficacy profile poorly characterized.

## Historical & Cultural Context

Hintonia latiflora has been documented in Mexican traditional medicine since at least the 16th century, with the bark recorded in the Florentine Codex—a comprehensive ethnographic work compiled by Fray Bernardino de Sahagún—as a remedy for gastrointestinal ailments. The plant holds significant cultural importance across indigenous and mestizo communities throughout western and southern Mexico, where it is widely known as 'copalchi' and used primarily to manage type 2 diabetes symptoms and digestive complaints including diarrhea and stomach pain. Preparation traditionally involves boiling the bark in water to produce a bitter decoction consumed orally, though leaf infusions represent an increasingly promoted alternative that reduces pressure on wild bark-harvested populations. The inclusion of H. latiflora bark in the Mexican Herbal Pharmacopoeia formalizes its status as an officially recognized herbal medicine within Mexico's regulatory framework, reflecting its deep integration into the country's ethnomedicinal heritage.

## Synergistic Combinations

Copalchi's α-glucosidase inhibitory mechanism is mechanistically complementary to berberine, which acts via AMPK activation and GLUT4 upregulation, and the combination may provide additive postprandial glucose control through distinct but convergent pathways. Chlorogenic acid present in copalchi extracts shares targets with green coffee bean extract and may synergize with other polyphenol-rich botanicals such as cinnamon bark (cinnamaldehyde-mediated insulin sensitization) to broaden antidiabetic activity across multiple glucose-regulatory mechanisms. Pairing with gastroprotective agents such as deglycyrrhizinated licorice (DGL) or mastic gum may amplify copalchi's mucosal-protective sulfhydryl-stimulating activity, supporting its traditional combined use for gastrointestinal and metabolic indications.

## Frequently Asked Questions

### Does copalchi lower blood sugar in humans?

No controlled human clinical trials have confirmed blood sugar reduction in human subjects. Preclinical evidence from streptozotocin-diabetic rat models shows statistically significant glucose reductions (p<0.05), and 4-phenylcoumarins inhibit α-glucosidase enzymes in vitro, providing biological plausibility, but human efficacy remains unproven pending clinical trials.

### Is copalchi safe to take daily?

Daily use of copalchi bark preparations carries a documented risk of acute hepatotoxicity, with case reports of elevated liver enzymes (ALT/AST) in continuous bark consumers. Leaf extracts appear non-toxic in acute animal studies per the Lorke protocol, but long-term human safety data are absent, and daily use—especially of bark—should be approached with caution and liver function monitoring.

### What are the active compounds in Hintonia latiflora?

The primary bioactive compounds are 4-phenylcoumarins—including desoxycordifolinic acid, 6′′-O-acetyl-5-O-β-D-galactopyranosyl-7,4′-dihydroxy-4-phenylcoumarin, and coutareagenin—along with chlorogenic acid, ursolic acid, and various polyphenols. Chlorogenic acid is the dominant compound in leaf infusions as identified by HPLC profiling, while 4-phenylcoumarins are considered the primary drivers of α-glucosidase inhibitory and hypoglycemic activity.

### How is copalchi traditionally prepared?

Traditionally, copalchi is prepared as a decoction by simmering bark pieces in water for 15–20 minutes to produce a bitter tea consumed one to two times daily, a method documented in Mexican folk medicine since the 16th century. Leaf infusions—dried leaves steeped in boiling water—are increasingly advocated as a sustainable and similarly active alternative that avoids pressure on wild bark-harvested populations.

### Can copalchi interact with diabetes medications?

Although no formal drug interaction studies exist, copalchi's demonstrated α-glucosidase inhibitory and hypoglycemic activity in animal models creates a theoretical risk of additive or synergistic hypoglycemia when combined with insulin, sulfonylureas, or other antidiabetic drugs. Patients using glucose-lowering medications should consult a healthcare provider before using copalchi preparations and monitor blood glucose closely if concurrent use occurs.

### What form of copalchi is most effective for blood sugar control?

Leaf and bark extracts of Hintonia latiflora have demonstrated the strongest antihyperglycemic effects in clinical research, with both showing statistically significant reductions in fasting and postprandial glucose levels. The 4-phenylcoumarins and chlorogenic acid in these extracts work by inhibiting intestinal α-glucosidases, which slows carbohydrate digestion. Whole plant preparations or tea infusions may be less standardized in their active compound concentration compared to concentrated extracts.

### Who should avoid taking copalchi supplements?

Pregnant and breastfeeding women should avoid copalchi due to insufficient safety data in these populations. Individuals already taking antidiabetic medications should consult a healthcare provider before use, as copalchi's blood glucose-lowering effects could amplify medication action. People with severe liver or kidney disease may also want to avoid this herb until more safety data becomes available.

### How strong is the scientific evidence supporting copalchi's blood sugar benefits?

Research on copalchi shows promising results, with leaf and bark extracts demonstrating statistically significant glucose reductions (p<0.05) in both normal and diabetic animal models. However, most published evidence comes from preclinical studies using streptozotocin-induced diabetic rats rather than large-scale human clinical trials. Additional human studies are needed to establish optimal dosing, long-term efficacy, and safety profiles before definitive clinical recommendations can be made.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*